What is a stock summary page? Click here for an overview.
Business Description
Clover Biopharmaceuticals Ltd
ISIN : KYG2280A1076
Compare
Compare
Traded in other countries / regions
02197.Hong Kong Index Membership
Hong Kong Stock Connect IPO Date
2021-11-05Description
Clover Biopharmaceuticals Ltd is a clinical-stage biotechnology company committed to developing novel vaccines and biologic therapeutic candidates for infectious diseases as well as cancer and autoimmune diseases.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.15 | |||||
| Equity-to-Asset | -0.46 | |||||
| Debt-to-Equity | -0.28 | |||||
| Debt-to-EBITDA | -0.28 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -6.75 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 64.9 | |||||
| 3-Year Book Growth Rate | 15 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 8.82 | |||||
| 9-Day RSI | 20.71 | |||||
| 14-Day RSI | 31.24 | |||||
| 3-1 Month Momentum % | 33.74 | |||||
| 6-1 Month Momentum % | 14.04 | |||||
| 12-1 Month Momentum % | -20.73 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.78 | |||||
| Quick Ratio | 0.44 | |||||
| Cash Ratio | 0.24 | |||||
| Days Inventory | 23748.75 | |||||
| Days Sales Outstanding | 103.38 | |||||
| Days Payable | 6073.4 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -3.8 | |||||
| Shareholder Yield % | 43.34 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 55.01 | |||||
| Operating Margin % | -1705.12 | |||||
| Net Margin % | -3038.12 | |||||
| FCF Margin % | -1579.95 | |||||
| ROA % | -38.11 | |||||
| ROIC % | -23.28 | |||||
| 3-Year ROIIC % | -32.01 | |||||
| ROC (Joel Greenblatt) % | -498.04 | |||||
| ROCE % | -988.37 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 0.29 | |||||
| PS Ratio | 9.96 | |||||
| EV-to-EBIT | -0.04 | |||||
| EV-to-Forward-EBIT | 0.02 | |||||
| EV-to-EBITDA | -0.04 | |||||
| EV-to-Forward-EBITDA | 0.01 | |||||
| EV-to-Revenue | 1.2 | |||||
| EV-to-FCF | -0.08 | |||||
| Earnings Yield (Greenblatt) % | -2500 | |||||
| FCF Yield % | -155.57 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Clover Biopharmaceuticals Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 31.782 | ||
| EPS (TTM) (HK$) | -0.775 | ||
| Beta | 3.05 | ||
| 3-Year Sharpe Ratio | -0.31 | ||
| 3-Year Sortino Ratio | -0.67 | ||
| Volatility % | 75.87 | ||
| 14-Day RSI | 31.24 | ||
| 14-Day ATR (HK$) | 0.021667 | ||
| 20-Day SMA (HK$) | 0.31195 | ||
| 12-1 Month Momentum % | -20.73 | ||
| 52-Week Range (HK$) | 0.201 - 0.58 | ||
| Shares Outstanding (Mil) | 1,296.29 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Clover Biopharmaceuticals Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Clover Biopharmaceuticals Ltd Stock Events
| Event | Date | Price (HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Clover Biopharmaceuticals Ltd Frequently Asked Questions
What is Clover Biopharmaceuticals Ltd(HKSE:02197)'s stock price today?
The current price of HKSE:02197 is HK$0.25. The 52 week high of HKSE:02197 is HK$0.58 and 52 week low is HK$0.20.
When is next earnings date of Clover Biopharmaceuticals Ltd(HKSE:02197)?
The next earnings date of Clover Biopharmaceuticals Ltd(HKSE:02197) is 2025-04-02 Est..
Does Clover Biopharmaceuticals Ltd(HKSE:02197) pay dividends? If so, how much?
Clover Biopharmaceuticals Ltd(HKSE:02197) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers